Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors

MeSH terms

• Adenosine Monophosphate / analogs & derivatives
• Adenosine Monophosphate / therapeutic use
• Aged
• Alanine / analogs & derivatives
• Alanine / therapeutic use
• Antineoplastic Agents / therapeutic use
• Antiviral Agents / therapeutic use
• Breast Neoplasms / complications
• Breast Neoplasms / pathology
• Breast Neoplasms / therapy
• COVID-19 / complications
• COVID-19 / diagnosis
• COVID-19 / therapy*
• COVID-19 Drug Treatment
• COVID-19 Nucleic Acid Testing
• COVID-19 Serological Testing
• COVID-19 Serotherapy
• Dexamethasone / therapeutic use
• Drug Combinations
• Female
• Follow-Up Studies
• Glucocorticoids / therapeutic use
• Humans
• Hydroxychloroquine
• Immunization, Passive
• Immunotherapy
• Latent Infection
• Lopinavir / therapeutic use
• Lung Neoplasms / complications
• Lung Neoplasms / pathology
• Lung Neoplasms / therapy
• Male
• Molecular Targeted Therapy
• Neoplasms / complications
• Neoplasms / pathology
• Neoplasms / therapy*
• Proportional Hazards Models
• Risk Factors
• Ritonavir / therapeutic use
• SARS-CoV-2
• Spain
• Time Factors
• Virus Shedding*